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Abstract
Background: Aneuploidies are copy number variants that affect entire chromosomes. They are seen commonly in
cancer, embryonic stem cells, human embryos, and in various trisomic diseases. Aneuploidies frequently affect only a
subset of cells in a sample; this is known as “mosaic” aneuploidy. A cell that harbours an aneuploidy exhibits disrupted
gene expression patterns which can alter its behaviour. However, detection of aneuploidies using conventional
single-cell DNA-sequencing protocols is slow and expensive.
Methods: We have developed a method that uses chromosome-wide expression imbalances to identify
aneuploidies from single-cell RNA-seq data. The method provides quantitative aneuploidy calls, and is integrated into
an R software package available on GitHub and as an Additional file of this manuscript.
Results: We validate our approach using data with known copy number, identifying the vast majority of aneuploidies
with a low rate of false discovery. We show further support for the method’s efficacy by exploiting allele-specific gene
expression levels, and differential expression analyses.
Conclusions: The method is quick and easy to apply, straightforward to interpret, and represents a substantial cost
saving compared to single-cell genome sequencing techniques. However, themethod is less well suited to data where
gene expression is highly variable. The results obtained from themethod can be used to investigate the consequences
of aneuploidy itself, or to exclude aneuploidy-affected expression values from conventional scRNA-seq data analysis.
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Background
Aneuploidies are gains or losses of entire chromosomes.
They occur commonly during early human development
[1], cause some human disease (Edwards, Patau and Down
syndromes), and are implicated in critical failures at the
pre-implantation stage of development [2]. While the
expression levels of genes on chromosomes with an ane-
uploidy are buffered in some cases, these mechanisms
rarely fully compensate for the additional or missing
gene copy and may only act on a gene-by-gene basis
[3]. Aneuploidy-driven expression changes have been
observed in yeast [4], Drosophila [5], and human cell lines
at both the mRNA and the protein level [6].
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Previous studies using array Comparative Genomic
Hybridisation (aCGH) [1] have shown that aneuploidies
that arise during very early embryonic development are
frequently mosaic in character, such that the copy num-
ber gain or loss only affects a fraction of the cells in the
embryo; these are referred to as mosaic aneuploidies. Sim-
ilarly, mosaic aneuploidy is observed in populations of
embryonic stem cells [7]. To properly characterise and
investigate mosaic aneuploidy, it is therefore necessary to
study individual cells rather than bulk populations.
Technological developments have facilitated the appli-
cation of genomics techniques at single-cell resolution.
This has allowed the genome, transcriptome, epigenome
and proteome of individual cells to be molecularly charac-
terised [8–12]. Furthermore, it has recently become possi-
ble to combine multiple sequencing modalities and apply
them to the same cell: for example, parallel genome and
transcriptome sequencing [13] (G&T-seq) has allowed
the integration of copy number and mRNA expression
information.
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Nevertheless, such combined profiling is relatively
unusual and most experiments focus on assaying only
a single molecular feature. In particular, most published
studies have focussed on single-cell RNA-sequencing
(scRNA-seq) [8, 14–16]. Consequently, and given the rel-
atively high prevalence of aneuploidies noted above, the
ability to call such features directly from scRNA-seq data
is highly desirable.
To this end, we have developed amethod for calling ane-
uploidies from scRNA-sequencing data and applied it to
a variety of different use cases. Our approach works by
statistically identifying, separately for each cell, chromo-
somes with genes that show consistently deviant expres-
sion compared to the same chromosome in other cells.
The efficacy of a similar approach has previously been
demonstrated using tumour samples [17], where different
clonal populations of cells could be visually distinguished.
However, that method does not make explicit ploidy calls.
Our method shows high levels of sensitivity and speci-
ficity when using known copy-number information from
G&T-seq data. Moreover, its predictions are supported
by allele-specific expression information and differential
expression analysis.
Methods
Let cgij denote the normalised (Counts Per Million, CPM)
expression level for gene g on chromosome i in cell j.
Furthermore, let
agij = cgijmedjcgij
denote the expression of gene g on chromosome i in cell
j normalized by the median expression of the same gene
across cells. We consider only highly expressed genes (see
“Operational information” section, below) to reduce the
effects of technical artefacts common to scRNA-seq as
well as to prevent occurrence of extreme values of agij.
Subsequently, for every cell-chromosome combination
we define
bij =
∑
g∈i
agij
bij depends on the number of genes g considered on
chromosome i. Tomake this sum comparable across chro-
mosomes, which contain different numbers of genes, we
normalise by the number of considered genes on each
chromosome, Gi:
rij = bijGi
Finally, within each cell, we convert this ratio into a score
centred at 1 across chromosomes:
sij = 1 + (rij − medirij)
Assuming that no chromosome within a cell has a copy
number gain or loss, sij will deviate randomly around 1.
By contrast, if specific chromosomes possess evidence of
an aneuploidy their scores will be elevated or reduced
accordingly. A graphical representation is shown in
Fig. 1a. Note that this interpretation assumes that the
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Fig. 1 Successful detection of aneuploidies from scRNA-seq data. a Overview of the method. Cells with aneuploid chromosomes (purple and green)
have altered levels of transcription of genes on the affected chromosome (less and more, respectively). For a given chromosome and cell, we
compute a score for how deviant the overall expression of genes on that chromosome is relative to that in other cells. bWe applied our method to
8-cell stage mouse embryos that were sequenced via a parallel genome and transcriptome method (G&T-seq). Our method performs well
compared to the ground truth provided by genomic sequencing (sensitivity 78.0%, specificity 99.5%, FDR 11.4%). The chromosome with high
Z-score in embryo F is not called as aneuploid as it does not pass an effect size threshold (“Methods” section)
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majority of chromosomes within a cell are not affected by
the same type of aneuploidy.
To infer whether a cell-chromosome displays aberrant
copy number, we converted sij into a Z-score, where the
variance was estimated separately for each chromosome
across cells using the median absolute deviation (MAD).
We identified aneuploid chromosomes using an FDR-
corrected p < 0.1, where the p-value was obtained using
Student’s t-distribution.
Operational information
As input, we considered all cells that passed quality con-
trol using the criteria employed in each analysed dataset.
We only consider highly expressed genes (median
CPM>50) to prevent inclusion of genes where small dif-
ferences in expression across cells could make large differ-
ences to agij.
Before utilising themethod, Principal Component Anal-
ysis (PCA) was applied to the log-transformed highly
expressed genes to identify substructure in the data.
The presence of sub-structure will be driven by differen-
tially expressed genes across cells. Consequently, jointly
analysing cells in this setting would result in chromosome
scores driven by differentially expressed genes rather than
aneuploidy. Therefore, if cell groupings were observed,
we assigned cells into different groups and analysed them
separately.
Finally, to call an aneuploidy we not only required that
the corrected p-value was less than 0.1, but also imposed
an effect size threshold such that cell-chromosomes where
0.8 < sij < 1.2 were not considered significant. This is
analogous to approaches commonly applied in microarray
and RNA-sequencing analyses when detecting differen-
tially expressed genes.
Allele-specific expression analysis
To identify biases in allele-specific expression that may
be indicative of aneuploidy we considered, for each cell-
chromosome, the total number of reads that could be
uniquely allocated to one allele. Subsequently, we com-
puted an allele-ratio as the ratio of the total number of
reads from one allele over the total number of reads that
could be uniquely assigned to either allele. To ensure the
median ratio was the same across all chromosomes, we
median centred the computed ratios on a per chromo-
some basis.
At different stages of embryonic development, progres-
sive activation of the paternal genome results in system-
atically different allele ratios between cells across stages.
To ensure that allele ratios were comparable between cells
of different stages, we additionally median centred the
allele ratios for all chromosomes in each embryo. This
step also corrects for further embryo-specific allele-ratio
biases.
Differential expression analysis
To find genes that were associated with aneuploidy, we
performed differential expression (DE) analysis using two
scRNA-seq datasets (mouse embryos [18] and mESCs
[19]). First, we subsetted the data such that it contained
only genes that are expressed at a mean level above
10 counts per million (CPM) or more in both datasets.
For each dataset, we subsequently performed differen-
tial expression analysis using edgeR [20] between cells
called as diploid and those that contain at least one
chromosome our method called as aneuploid. We added
batch (for the mESCs) and embryo number (for the
embryos) as covariates to account for technical effects.
We called differentially expressed genes as those with an
FDR-corrected p < 0.1.
We considered genes that were either downregulated in
both datasets or upregulated in both datasets as a high-
confidence set of genes that have altered expression levels
in aneuploid cells.
Results
To detect aneuploidies from scRNA-sequencing data we
computed, for a defined group of cells, a score for each
chromosome-cell pair that measures whether the expression
level of genes in that chromosome differs substantially
from other cells. We converted this score into a p-value
and used this to detect significant deviations, which we
interpret as providing evidence for the presence of an ane-
uploidy (“Methods” section). The algorithm is available
in an R package (scploid) provided in Additional file 1,
with the latest version also available at https://github.com/
MarioniLab/Aneuploidy2017.
True aneuploidies are detected at a low false positive rate
To assess our method’s performance, we first applied it
to a dataset where DNA copy number was known. This
dataset processed cells from 8-cell stage mouse embryos
using a combined genome-and-transcriptome (G&T-seq)
strategy [13]. Here, the mRNA and DNA from a single
cell are physically separated from one another and pro-
cessed in parallel to provide transcriptomic and genomic
information about the same cell. We therefore used the
genomic copy number calls to assess our method’s perfor-
mance on the transcriptome data.
Grouping cells by treatment (reversine or control), our
method identified aneuploidies with a sensitivity of 78.0%
(from 50 real aneuploidies) and FDR of 11.4% (Fig. 1b).
Importantly, for chromosomes with no evidence of copy
number changes, the p-values derived from the Z-scores
were uniformly distributed, suggesting the assumptions
made by our model are reasonable (see Additional file 2:
Figures S3–S4). Of the 11 false negative aneuploidy calls,
8 were found in the aneuploidy rich embryo E, which
showed considerably increased incidence of aneuploidy
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compared to the other embryos. These chromosomes fre-
quently showed low levels of total expression deviation
compared to normal ploidy chromosomes (Additional
file 2: Figure S10). By contrast, the 5 false positives
were spread across embryos and chromosomes. We did
not call any aneuploidies in the control (non-treated)
cells, concordant with DNA sequencing copy number
calls.
High gene expression variance confounds our model
In addition, G&T-sequencing was also applied to cells
from an immortalized lymphoblastoid cell line, HCC38-
BL [13]. Although derived from normal (primarily diploid)
cells, G&T-sequencing identified seven copy number
changes (three of which affected only one chromosomal
arm). Our method identified only two of these changes,
albeit the remaining aneuploid chromosomes had scores
that were consistent with the change in copy number but
not statistically significant. Our method also made sev-
eral false positive calls. Performance metrics are shown
in Fig. 2a.
To explore what might underpin this observation, we
investigated the scRNA-sequencing data derived from
these cells in greater detail. Relative to the 8-cell embryo
cells, the expression profiles of the HCC38-BL cells were
more variable (Fig. 2b). To investigate how this increased
variance might affect the performance of our method, we
simulated data based upon the 8-cell stage data intro-
duced earlier. This allowed us to adjust the degree of
variability in expression while realistically controlling for
both gene expression levels and the relationship between
variability and expression (Fig. 2c, Additional file 2:
Section 3.4).
Simulations where the mean-variance relationship was
similar to the real 8-cell embryo data yielded performance
approximately equal to that of the real data. However,
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Fig. 2 High variability in gene expression levels compromises performance. a Our method performs less well on cell-line G&T-sequencing data than
on the mouse embryos. All cells were considered for the 8-cell embryos and HCC38-BL data. Trisomy 21 cells were downsampled to a ratio of 1 T21
cell : 4 control cells (normal ploidy chromosome 21), to ensure that these aneuploidies were in the minority and therefore can be detected. b The
datasets with poor performance showmore variable gene expression profiles. For 500 genes selected at random from each dataset (navy: HCC38-BL
cell line; yellow: Reversine-treated 8-cell embryos; cyan: trisomy 21 iPS derived neurons) we plot the (log) standard deviation of expression (y − axis)
against the (log) mean expression (x − axis). A linear model was fitted separately for each dataset using genes with a median count (per million
reads) of at least 50 and overlaid. c Simulated datasets with different dispersion parameters are shown. We simulated four datasets to assess the
impact of gene expression variability on the performance of our method. Genes from each simulation are shown and the different dispersion
parameters used in the simulation are noted. The regression lines from the fit in 2b are overlaid. d As the data become more variable, the
performance of our method degrades. For simulations with variability comparable to the HCC38-BL and Trisomy 21 neuron datasets, the sensitivity
and precision are considerably impacted. Reported values are the mean of 10 simulations
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when we increased the level of variability in the expres-
sion profiles to that observed in the HCC38-BL cells, we
observed a substantial decrease in the performance of our
approach (see Fig. 2d). Similar behaviour was observed
in the final set of cells profiled using the G&T protocol,
a set of Trisomy 21 and normal ploidy neurons derived
from induced pluripotent stem cells (Additional file 2:
Section 4).
In sum, the relatively poor performance of our approach
when applied to both simulated and real data with
higher levels of variance in gene expression levels across
cells demonstrates that our ability to detect copy num-
ber changes is, unsurprisingly, heavily influenced by the
underlying variability in the analysed expression profiles
(see “Discussion” section).
Using allele specific expression to validate copy number
calls
It has been reported that the quality of scRNA-seq
data derived using joint protocols is less consistent and
sometimes lower in quality than when only the mRNA
is profiled [21]. Given the relationship between our
method’s performance and the amount of noise in the data
(explored using the simulations above), we thus applied
it to conventional scRNA-seq data. Importantly, we con-
sidered scRNA-seq data generated from F1 intercrosses
between two inbred strains of mice [18, 19], where each
allele is derived from a distinct genetic background.
The presence of an aneuploidy will create an imbalance
between the copy numbers of alleles from the affected
chromosome, which should lead to an expression imbal-
ance between the two sets of alleles. While this does
not provide as definitive a conclusion as DNA sequenc-
ing data, a cell that contains such an expression imbal-
ance is nonetheless more likely to contain an aneuploidy.
This approach, which considers only the allele-specific
expression counts, is orthogonal to our existing method,
which considers the total gene expression levels. There-
fore agreement between the two approaches would offer
support for the efficacy of our method without the use of
G&T-seq.
Specifically, we have considered a set of F1 cells derived
from the embryos of C57BL/6J× CAST/EiJ mice (two cell
stage to late blastocyst) [18]. First, we applied our ane-
uploidy detection method on total expression levels to
identify candidate aneuploidies. Independently, we con-
sidered the allele-specific counts, recording the relative
contribution to each chromosome’s total allele-mappable
expression from each set of alleles. Chromosomes that
score highly in our total expression method show sig-
nificantly higher levels of deviation from balanced allelic
expression than other chromosomes (p < 10−9; Fig. 3a),
thus supporting the validity of our aneuploidy calls. We
noted that monosomic-called chromosomes show more
severe deviation than those called as trisomic (Fig. 3b), as
expected from the total absence of an allele set in cases
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Fig. 3 Allele-specific expression datasets support the method’s aneuploidy calls. a Chromosomes with higher-confidence aneuploidy calls show
greater allele-specific expression (ASE) deviation than cells that are not called (p < 10−9, Mann-Whitney U test). The ASE deviation was corrected for
systematic ASE differences for each embryo and for each autosome (Methods). Z-scores to the right of the dashed line are significant after
FDR-correction. Values above Z-score bins are the number of chromosomes in each bin. b Trisomic and monosomic chromosomes show greater
ASE deviation than chromosomes with normal-ploidy (p < 10−8 and p < 10−2, respectively; Mann-Whitney U test). Black circles indicate the mean
deviation. Violin plots are area normalised. Values above the plots are the number of chromosomes considered
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of monosomy compared to a smaller change in allele pro-
portion in trisomies. We observed very similar behaviour
in another F1 cross dataset of cultured mouse embryonic
stem cells [19] (see Additional file 2: Section 6).
Differential expression analysis identifies genes associated
with aneuploidy
To explore the utility of the aneuploidy predictions made
by our method, we next performed transcriptome-wide
differential expression analysis between all cells called as
aneuploid (irrespective of the affected chromosome(s))
and those called as diploid in the two large scRNA-seq
datasets analysed above (mouse embryos [18] and cul-
tured mESCs [19]). In total, we identified 22 genes that
were commonly upregulated in aneuploid cells in both
datasets (“Methods” section & Additional file 2: Section 8;
FDR <0.1). No shared downregulated genes were found.
Of these genes, a number show particular relevance
for aneuploidy: Gas5 is a noncoding RNA with roles
in growth arrest [22] and apoptosis [23]; Txnip overex-
pression results in G1 cell-cycle arrest [24]; and Rps27l
overexpression has been shown to promote p53 activity
[25], resulting in cell-cycle arrest and apoptosis. Apoptotic
and growth arrest functions are known to be associated
with aneuploidy [26].
The activation of the unfolded protein response is also
linked with aneuploidy [27]. Three of the differentially
expressed genes have roles in this pathway: Calnexin
(Canx), Pdia3 [28], and Sdf2 [29]. Sdf2 differential expres-
sion is additionally associated with human oocyte aneu-
ploidy [30].
The roles of many of these differentially expressed genes
in aneuploidy-related pathways provides further support
for the performance of our method.
Discussion
Our analysis demonstrates that changes in DNA copy
number at the single-cell level can be inferred directly
from single-cell RNA-sequencing data. One significant
caveat is the relationship between the method’s perfor-
mance and the degree of noise in the data; such an
increase in noise can be driven by several factors. Het-
erogeneity between cell populations, if not accounted for
by clustering cells into homogeneous groups, can lead
to systematic chromosome score differences as a result
of genes being differentially expressed between popula-
tions. Furthermore, cells that are transcriptionally more
variable increase the amount of aneuploidy-independent
gene expression variance present, which compromises our
method’s performance. Such an increase in variance can
be driven by technical and biological effects, the former of
which is particularly relevant for scRNA-seq, where dif-
ferent protocols generate different amounts of technical
noise [31].
Despite this, we demonstrate the good performance of
our method across a variety of cell types and conditions.
In practice, we suggest that a user exercise caution over
the following characteristics of their data. Subpopulations
of cells should be identified and analysed separately to
reduce aneuploidy-independent expression variance, akin
to new approaches for normalising scRNA-seq data [32].
The method should be applied to cells that are relatively
phenotypically normal (for example, large genome rear-
rangements move cells away from integer copy number
values and hinder chromosomal gene assignment).
Additionally, as for all scRNA-sequencing analysis
approaches, the degree of noise in the data is vital.
We have identified three easily computable metrics to
assess this: a gene-wise score that captures increased or
decreased expression variability compared to the G&T-
seq 8-cell embryos; the total number of genes that qualify
as highly expressed (median CPM > 50); and the fraction
of zero counts observed in these genes — a lower vari-
ability score, more available genes, and fewer zeros are
features that enable application of our method. Impor-
tantly, when applying these metrics to recently generated
single-cell RNA-seq datasets [16, 33] we observed that the
method appears to be well suited to analyse contempo-
rary scRNA-seq data (see Additional file 2: Section 7 for
further detail of these metrics and datasets).
One further concern is whether cells captured at dif-
ferent stages of the cell cycle will lead to differences in
copy number driven by variability in the process by which
chromosomes are replicated. However, previous work has
suggested that dosage control is tightly regulated dur-
ing the cell cycle [34], mitigating this effect. Additionally,
when using an existing classifier to assign the mESCs and
developing mouse embryos analysed above to different
cell cycle phases [35], we did not observe an associa-
tion between the degree of aneuploidy and cell cycle (see
Additional file 2: Section 9).
Moving forward, it may be possible to integrate more
information to increase predictive power. For example,
classifiers have previously been trained to identify ane-
uploid cells based on specific transcriptional signatures
[36]. Alternatively, where possible, allele-specific expres-
sion information could be coupled with total expression
data, which would be especially helpful when detecting
copy number deletion events.
Having acquired ploidy information about a single-cell
RNA-seq dataset through this method, the results can
be exploited in a number of ways to obtain further bio-
logical insight. For example, gene expression counts on
chromosomes that are suspected to be aneuploid may be
excluded when selecting highly variable genes [37] to pre-
vent propagation of aneuploidy-driven signal into down-
stream analyses. Additionally, as shown above, segregat-
ing cell-chromosomes by whether or not they harbour
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an aneuploidy can help identify genes that are potentially
associated with copy number aberrations.
The methodmay provide particular benefits in stem cell
and embryonic research, where aneuploidies are known
to be common [2, 7, 38] and single-cell approaches have
been widely applied. Additionally, the method is straight-
forward to apply (requiring no additional experimental
work) and easy to interpret, yielding direct aneuploidy
calls for each cell-chromosome unlike previous strategies
[17]. Application of this method also represents a con-
siderable cost saving compared to expensive and exper-
imentally more complex single-cell genome sequencing
protocols [39].
Conclusions
In this paper, we have shown that chromosome-wide
imbalances in mRNA gene expression measured using
scRNA-seq can be used to identify aneuploidy. We have
demonstrated this using ground-truth ploidy knowledge
(parallel genomic & transcriptomic sequencing), allele-
specific expression ratios over chromosomes, and differ-
ential expression between cells with and without called
aneuploidies. The method is straightforward to apply,
albeit care must be taken to control for potential con-
founding factors. Downstream applications include iden-
tification of aneuploidies for gaining insight into their
cause and / or consequences, as well as to exclude expres-
sion values from aneuploid chromosomes to improve the
accuracy of common analysis techniques.
Additional files
Additional file 1: Code for analysis. A gzipped tarball containing all code
used for analysis, as well as the .html report referred to above. A package to
run aneuploidy assessment in R is also included, alongside a script to
download the data we have used. The latest version of these files may be
found on https://github.com/MarioniLab/Aneuploidy2017. (GZ 6405 kb)
Additional file 2: Analysis report. A .html file that details all the analysis
included herein, including additional figures referred to in the manuscript
as well as some further analyses. (HTML 8315 kb)
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